EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Effects of Oral Taurine Supplementation on Cardiometabolic Risk Factors: A Meta-analysis and Systematic Review of Randomized Clinical Trials

Zizheng Nie, Yingying Liu, Mu Zhang, Chenyang Wu, Qinglong Cao, Jiaoyang Xu, Yiren Zheng, Zixin Min, Weiguo Zhang iD, Shufen Han iD

Nutrition Reviews · 2026

DOI: 10.1093/nutrit/nuaf220 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Nutrition Reviews, 2026. Verfasst von Zizheng Nie und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Toxicology, School of Public Health, Hangzhou Normal University, Hangzhou, Zhejiang 311121, P.R. China. Hauptthemen laut MEDLINE: Taurine, Dietary Supplements, Cardiometabolic Risk Factors, Cardiovascular Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: Scientific Research Foundation for Scholars, Scientific Research Foundation for Scholars of HZNU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Taurine, a sulfur-containing amino acid vital for cardiovascular health, is suggested as a promising intervention for reducing cardiometabolic disease risk.

Objective

In this meta-analysis of randomized controlled trials (RCTs) we sought to evaluate the effects of taurine on cardiometabolic risk factors. Data sources We systematically searched PubMed/MEDLINE, Web of Science, EMBASE, Cochrane Library, and Google Scholar for articles reporting RCTs that investigated the effects of taurine on cardiometabolic risk factors. Data extraction Data extraction was performed in accordance with the Cochrane and PRISMA guidelines. A random-effects model or a common-effect model was used to calculate mean differences (MDs) or standardized mean differences (SMDs). Data analyses Thirty-four eligible RCTs were analyzed. Taurine supplementation resulted in significant reductions in fasting blood glucose (MD, −5.90 mg/dL; 95% CI, −9.65 to −2.15), glycated hemoglobin A1c (MD, −0.21%; 95% CI, −0.37 to −0.05), fasting insulin (SMD, −0.55; 95% CI, −0.78 to −0.32), homeostatic model assessment for insulin resistance index (MD, −0.57; 95% CI, −0.74 to −0.40), triglycerides (MD, −14.42 mg/dL; 95% CI, −23.60 to −5.25), total cholesterol (MD, −12.41 mg/dL; 95% CI, −19.10 to −5.71), low-density lipoprotein cholesterol (MD, −5.08 mg/dL; 95% CI, −8.35 to −1.81), systolic blood pressure (MD, −4.38 mmHg; 95% CI, −7.26 to −1.50), diastolic blood pressure (MD, −2.54 mmHg; 95% CI, −3.97 to −1.11), aspartate aminotransferase (MD, −9.65 U/L; 95% CI, −17.39 to −1.90), alanine aminotransferase (MD, −8.26 U/L; 95% CI, −14.81 to −1.70), C-reactive protein (SMD, −1.26; 95% CI, −2.01 to −0.52), tumor necrosis factor-α (MD, −0.35 pg/mL; 95% CI, −0.56 to −0.14), and malondialdehyde (SMD, −1.16; 95% CI, −1.81 to −0.52). Subgroup and dose–response analyses indicated that a daily taurine dose of 1.5-3.0 g was more effective in improving these cardiometabolic risk factors. Specifically, taurine intervention for ≥8 weeks yielded greater improvements in glucose and lipid metabolism, while durations <8 weeks were optimal for managing blood pressure and inflammation.

Conclusion

Taurine supplementation may effectively improve cardiometabolic risk factors in adults, underscoring its potential to reduce the incidence of cardiometabolic diseases. Systematic Review Registration PROSPERO registration No. CRD42024577852.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TaurineDietary SupplementsCardiometabolic Risk FactorsCardiovascular DiseasesHumansRandomized Controlled Trials as TopicBlood GlucoseInsulinInsulin ResistanceGlycated HemoglobinRisk FactorsTriglyceridesBlood Pressure

Stichwörter der Autor:innen

cardiometabolic diseasemeta-analysispublic healthrisk markerstaurine

Substanzen

TaurineBlood GlucoseInsulinGlycated HemoglobinTriglycerides

Autor:innen und Institutionen

  • Department of Nutrition and Toxicology, School of Public Health, Hangzhou Normal University, Hangzhou, Zhejiang 311121, P.R. China.
  • Las Colinas Institutes, Irving, TX 75039, United States.

ORCID-Profile: Weiguo Zhang, Shufen Han

Förderung

  • Scientific Research Foundation for Scholars
  • Scientific Research Foundation for Scholars of HZNU

Zitieren

APA

Nie, Z., Liu, Y., Zhang, M., Wu, C., Cao, Q., Xu, J., Zheng, Y., Min, Z., Zhang, W., & Han, S. (2026). Effects of Oral Taurine Supplementation on Cardiometabolic Risk Factors: A Meta-analysis and Systematic Review of Randomized Clinical Trials. Nutrition Reviews. https://doi.org/10.1093/nutrit/nuaf220

Vancouver

Nie Z, Liu Y, Zhang M, Wu C, Cao Q, Xu J, et al. Effects of Oral Taurine Supplementation on Cardiometabolic Risk Factors: A Meta-analysis and Systematic Review of Randomized Clinical Trials. Nutrition Reviews. 2026. doi:10.1093/nutrit/nuaf220

BibTeX
@article{Nie2026,
  author = {Nie, Zizheng and Liu, Yingying and Zhang, Mu and Wu, Chenyang and Cao, Qinglong and Xu, Jiaoyang and Zheng, Yiren and Min, Zixin and Zhang, Weiguo and Han, Shufen},
  title = {Effects of Oral Taurine Supplementation on Cardiometabolic Risk Factors: A Meta-analysis and Systematic Review of Randomized Clinical Trials},
  journal = {Nutrition Reviews},
  year = {2026},
  doi = {10.1093/nutrit/nuaf220}
}
Kostenlos starten →